Variant report

Variant	esv3407673
Chromosome Location	chr19:18941977-18944525
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:683)
CpG islands
(count:489)
Chromatin interactive
region (count:9)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:683 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:18942668-18942769	K562	blood:	n/a	n/a
2	ATF3	chr19:18942544-18942825	K562	blood:	n/a	n/a
3	BCL11A	chr19:18942409-18942702	GM12878	blood:	n/a	chr19:18942615-18942628
4	BCLAF1	chr19:18942493-18943000	GM12878	blood:	n/a	chr19:18942959-18942972 chr19:18942961-18942970 chr19:18942615-18942628
5	BHLHE40	chr19:18942471-18942890	GM12878	blood:	n/a	chr19:18942612-18942628 chr19:18942560-18942576 chr19:18942871-18942887
6	BHLHE40	chr19:18942420-18942821	K562	blood:	n/a	chr19:18942612-18942628 chr19:18942560-18942576
7	CBX3	chr19:18943406-18943798	K562	blood:	n/a	n/a
8	CCNT2	chr19:18942510-18943765	K562	blood:	n/a	chr19:18942640-18942649
9	CEBPB	chr19:18942585-18942639	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr19:18944072-18944209	K562	blood:	n/a	n/a
11	CEBPD	chr19:18942341-18942981	HepG2	liver:	n/a	n/a
12	CHD1	chr19:18942875-18944075	H1-hESC	embryonic stem cell:	n/a	n/a
13	CHD1	chr19:18942377-18942458	H1-hESC	embryonic stem cell:	n/a	n/a
14	CHD1	chr19:18942180-18944332	IMR90	lung:	n/a	n/a
15	CHD1	chr19:18943955-18944054	GM12878	blood:	n/a	n/a
16	CHD1	chr19:18942747-18943685	GM12878	blood:	n/a	n/a
17	CHD2	chr19:18942589-18942910	Hela-S3	cervix:	n/a	n/a
18	CHD2	chr19:18942387-18942834	H1-hESC	embryonic stem cell:	n/a	n/a
19	CHD2	chr19:18943490-18943610	K562	blood:	n/a	n/a
20	CHD2	chr19:18942350-18942956	GM12878	blood:	n/a	n/a
21	CHD2	chr19:18942907-18942965	K562	blood:	n/a	n/a
22	CREB1	chr19:18942465-18942978	A549	lung:	n/a	n/a
23	CTCF	chr19:18943560-18943710	HEEpiC	esophagus:	n/a	n/a
24	CTCF	chr19:18943540-18943690	GM12864	blood:	n/a	n/a
25	CTCF	chr19:18943050-18943130	GM12891	blood:	n/a	n/a
26	CTCF	chr19:18942920-18943070	K562	blood:	n/a	n/a
27	CTCF	chr19:18943500-18943650	HepG2	liver:	n/a	n/a
28	CTCF	chr19:18943560-18943710	GM12875	blood:	n/a	n/a
29	CTCF	chr19:18943480-18943630	GM12878	blood:	n/a	n/a
30	CTCF	chr19:18943001-18943180	K562	blood:	n/a	n/a
31	CTCF	chr19:18942980-18943130	SK-N-SH_RA	brain:	n/a	n/a
32	CTCF	chr19:18943612-18943662	Pancreas_OC	pancreas:	n/a	n/a
33	CTCF	chr19:18943500-18943650	GM12874	blood:	n/a	n/a
34	CTCF	chr19:18943540-18943700	Hela-S3	cervix:	n/a	n/a
35	CTCF	chr19:18943520-18943670	BJ	skin:	n/a	n/a
36	CTCF	chr19:18943560-18943710	GM12873	blood:	n/a	n/a
37	CTCF	chr19:18943940-18944090	HCPEpiC	choroid plexus:	n/a	n/a
38	CTCF	chr19:18943560-18943710	GM06990	blood:	n/a	n/a
39	CTCF	chr19:18943440-18943590	NB4	blood:	n/a	n/a
40	CTCF	chr19:18943600-18943750	GM12873	blood:	n/a	n/a
41	CTCF	chr19:18942780-18942930	GM12867	blood:	n/a	n/a
42	CTCF	chr19:18943520-18943670	HPAF	blood vessel:	n/a	n/a
43	CTCF	chr19:18942660-18942810	AoAF	blood vessel:	n/a	n/a
44	CTCF	chr19:18943155-18943157	K562	blood:	n/a	n/a
45	CTCF	chr19:18943620-18943770	NHEK	skin:	n/a	n/a
46	CTCF	chr19:18943580-18943730	WI-38	lung:	n/a	n/a
47	CTCF	chr19:18943560-18943710	NHEK	skin:	n/a	n/a
48	CTCF	chr19:18942840-18943130	GM12864	blood:	n/a	n/a
49	CTCF	chr19:18942980-18943130	GM12872	blood:	n/a	n/a
50	CTCF	chr19:18943538-18943687	Fibrobl	skin:	n/a	n/a

(count:489 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:18942619-18942669	ECC-1	luminal epithelium:	n/a
2	chr19:18942619-18942669	ECC-1	luminal epithelium:	n/a
3	chr19:18942465-18942515	Caco-2	colon:	n/a
4	chr19:18943093-18943143	IMR90	lung:	fetal
5	chr19:18942465-18942515	AG09319	gingival:	n/a
6	chr19:18943821-18943871	HMEC	breast:	n/a
7	chr19:18943093-18943143	Jurkat	blood:	n/a
8	chr19:18943093-18943143	ECC-1	luminal epithelium:	n/a
9	chr19:18942575-18942625	NHDF-neo	bronchial:	n/a
10	chr19:18942575-18942625	LNCaP	prostate:	n/a
11	chr19:18943821-18943871	AG10803	skin:	n/a
12	chr19:18943821-18943871	AG09309	skin:	n/a
13	chr19:18942619-18942669	HAEpiC	amniotic membrane:	n/a
14	chr19:18943821-18943871	NH-A	brain:	n/a
15	chr19:18942575-18942625	AG04450	lung:	fetal
16	chr19:18942465-18942515	SK-N-SH_RA	brain:	n/a
17	chr19:18942500-18942550	PrEC	prostate:	n/a
18	chr19:18943821-18943871	HCF	heart:	n/a
19	chr19:18943093-18943143	MCF-7	breast:	n/a
20	chr19:18942465-18942515	NHBE	bronchial:	n/a
21	chr19:18942619-18942669	SK-N-SH	brain:	n/a
22	chr19:18943821-18943871	IMR90	lung:	fetal
23	chr19:18942575-18942625	ovcar-3	ovarian:	n/a
24	chr19:18942500-18942550	PFSK-1	brain:	n/a
25	chr19:18942575-18942625	SKMC	muscle:	n/a
26	chr19:18942818-18942868	HIPEpiC	eye:	n/a
27	chr19:18942500-18942550	AG09319	gingival:	n/a
28	chr19:18942619-18942669	HL-60	blood:	n/a
29	chr19:18943821-18943871	GM12878	blood:	n/a
30	chr19:18942513-18942563	GM06990	blood:	n/a
31	chr19:18942500-18942550	H1-hESC	embryonic stem cell:	embryo
32	chr19:18943821-18943871	T-47D	breast:	n/a
33	chr19:18942575-18942625	HMEC	breast:	n/a
34	chr19:18943093-18943143	HPAEpiC	pulmonary alveolar:	n/a
35	chr19:18943093-18943143	BE2_C	brain:	n/a
36	chr19:18942465-18942515	ovcar-3	ovarian:	n/a
37	chr19:18942619-18942669	MCF-7	breast:	n/a
38	chr19:18942575-18942625	Hepatocyte	liver:	n/a
39	chr19:18942500-18942550	U87	brain:	n/a
40	chr19:18942500-18942550	NH-A	brain:	n/a
41	chr19:18942575-18942625	SK-N-SH	brain:	n/a
42	chr19:18942818-18942868	ovcar-3	ovarian:	n/a
43	chr19:18942818-18942868	SAEC	small airway:	n/a
44	chr19:18942575-18942625	GM06990	blood:	n/a
45	chr19:18943821-18943871	Jurkat	blood:	n/a
46	chr19:18942465-18942515	MCF10A-Er-Src	breast:	n/a
47	chr19:18942575-18942625	IMR90	lung:	fetal
48	chr19:18942513-18942563	Hela-S3	cervix:	n/a
49	chr19:18942465-18942515	HRCEpiC	kidney:	n/a
50	chr19:18942575-18942625	NH-A	brain:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:18898066..18901050-chr19:18943953..18945970,2	K562	blood:
2	chr19:18942543..18946544-chr19:19028586..19032596,4	MCF-7	breast:
3	chr19:18704569..18706809-chr19:18943109..18944717,2	K562	blood:
4	chr19:18943201..18946442-chr19:18960453..18965147,6	MCF-7	breast:
5	chr19:18942447..18943029-chr5:432096..432879,2	NB4	blood:
6	chr19:18792191..18795996-chr19:18942387..18945269,3	MCF-7	breast:
7	chr19:18546771..18549506-chr19:18943551..18946783,3	K562	blood:
8	chr19:18899550..18903298-chr19:18943373..18946094,3	K562	blood:
9	chr19:18943405..18943938-chr19:19173944..19174627,2	MCF-7	breast:

No data

Variant related genes	Relation type
UPF1	TF binding region
UPF1	CpG island
ENSG00000105671	chromatin interactions
ENSG00000105664	chromatin interactions
ENSG00000105662	chromatin interactions
ENSG00000005007	chromatin interactions
ENSG00000105655	chromatin interactions
ENSG00000063438	chromatin interactions
ENSG00000006016	chromatin interactions
ENSG00000105669	chromatin interactions

Extended variants
information (count: 89 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:89 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs183804933	chr19:18942045-18942046	Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs185473367	chr19:18942058-18942059	Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs542261395	chr19:18942063-18942064	Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs112286826	chr19:18942108-18942109	Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs562191728	chr19:18942112-18942113	Enhancers Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs530998407	chr19:18942130-18942131	Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs149832019	chr19:18942176-18942177	Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs565540961	chr19:18942186-18942187	Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs564418795	chr19:18942191-18942192	Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs527988924	chr19:18942320-18942321	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs113905689	chr19:18942374-18942375	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs533418754	chr19:18942393-18942394	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs546295037	chr19:18942478-18942479	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs566422686	chr19:18942517-18942518	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs2238652	chr19:18942559-18942560	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs376031393	chr19:18942564-18942565	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs55824320	chr19:18942582-18942583	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs538014574	chr19:18942616-18942617	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs144682906	chr19:18942630-18942631	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs8105827	chr19:18942648-18942649	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs571578298	chr19:18942680-18942681	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs534049757	chr19:18942695-18942696	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs553095129	chr19:18942759-18942760	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs573187170	chr19:18942773-18942774	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs566921238	chr19:18942780-18942781	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs555425598	chr19:18942809-18942810	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs575461697	chr19:18942818-18942819	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs4808161	chr19:18942888-18942889	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs564305653	chr19:18942920-18942921	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs368452687	chr19:18942969-18942970	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs533467112	chr19:18942974-18942975	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs577137369	chr19:18942996-18942997	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs370409504	chr19:18943002-18943003	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs201726058	chr19:18943039-18943040	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs199755973	chr19:18943079-18943080	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs200829481	chr19:18943080-18943081	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs540877955	chr19:18943108-18943109	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs374572356	chr19:18943124-18943125	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs147358907	chr19:18943132-18943133	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs139448059	chr19:18943154-18943155	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs80065570	chr19:18943156-18943157	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs528873711	chr19:18943172-18943173	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs368132706	chr19:18943178-18943179	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs12976276	chr19:18943198-18943199	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs12976930	chr19:18943199-18943200	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs17339451	chr19:18943223-18943224	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
47	rs548841117	chr19:18943259-18943260	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
48	rs568993718	chr19:18943274-18943275	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
49	rs531398545	chr19:18943319-18943320	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
50	rs554383757	chr19:18943372-18943373	Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Medulloblastoma	16783165	CNVD
Follicular lymphoma	20505157	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Non-syndromic sensorineural hearing loss	20179077	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21080181	CNVD
Metanephric adenoma	20802469	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	16608533	CNVD
Lung cancer	17297452	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Chordoma	18071362	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
ovarian endometriomas	16273235	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Cervical cancer	21063398	CNVD
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Ovarian cancer	21720365	CNVD
Urothelial carcinoma	21177765	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Basal cell lymphoma	21115979	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21364760	CNVD
Mycobacterial infection	18421352	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute monocytic leukemia	16498392	CNVD
Lung cancer	18438408	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Liver carcinoma	19366792	CNVD
Colorectal cancer	19455253	CNVD
Lujan-Fryns syndrom	21521776	CNVD
Breast cancer	20409316	CNVD
Cancer	17160897	CNVD
Cancer	17440070	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Breast cancer	21509527	CNVD
Bladder cancer	21909424	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:387 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:18941600-18942200	Active TSS	Primary T helper cells PMA-I stimulated	--
2	chr19:18941600-18942200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
3	chr19:18941600-18943800	Active TSS	Duodenum Mucosa	Duodenum
4	chr19:18942000-18942200	Enhancers	Primary B cells from peripheral blood	blood
5	chr19:18942000-18942200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
6	chr19:18942000-18942200	Enhancers	Primary hematopoietic stem cells	blood
7	chr19:18942000-18942200	Enhancers	Primary hematopoietic stem cells short term culture	blood
8	chr19:18942000-18942200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
9	chr19:18942000-18942200	Enhancers	Primary T helper naive cells from peripheral blood	blood
10	chr19:18942000-18942200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
11	chr19:18942000-18942200	Enhancers	Primary T helper cells fromperipheralblood	blood
12	chr19:18942000-18942200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
13	chr19:18942000-18942200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
14	chr19:18942000-18942200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
15	chr19:18942000-18942200	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
16	chr19:18942000-18942200	Enhancers	Adipose Nuclei	Adipose
17	chr19:18942000-18942200	Enhancers	Liver	Liver
18	chr19:18942000-18942200	Enhancers	Brain Anterior Caudate	brain
19	chr19:18942000-18942200	Enhancers	Placenta	Placenta
20	chr19:18942000-18942200	Enhancers	Stomach Smooth Muscle	stomach
21	chr19:18942000-18942200	Enhancers	GM12878-XiMat	blood
22	chr19:18942000-18942200	Enhancers	Hela-S3	cervix
23	chr19:18942000-18942200	Enhancers	HMEC	breast
24	chr19:18942200-18942400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
25	chr19:18942200-18942400	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
26	chr19:18942200-18942400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
27	chr19:18942200-18942400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr19:18942200-18942400	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr19:18942200-18942400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr19:18942200-18942400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
31	chr19:18942200-18942400	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
32	chr19:18942200-18942400	Flanking Bivalent TSS/Enh	Fetal Intestine Large	intestine
33	chr19:18942200-18942400	Flanking Active TSS	Fetal Lung	lung
34	chr19:18942200-18942400	Flanking Active TSS	Fetal Muscle Trunk	muscle
35	chr19:18942200-18942400	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
36	chr19:18942200-18942400	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
37	chr19:18942200-18942400	Flanking Active TSS	Thymus	Thymus
38	chr19:18942200-18942600	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
39	chr19:18942200-18942600	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
40	chr19:18942200-18942600	Flanking Active TSS	Primary B cells from cord blood	blood
41	chr19:18942200-18942600	Flanking Active TSS	Primary B cells from peripheral blood	blood
42	chr19:18942200-18942600	Flanking Active TSS	Primary T cells fromperipheralblood	blood
43	chr19:18942200-18942600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
44	chr19:18942200-18942600	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
45	chr19:18942200-18942600	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
46	chr19:18942200-18942600	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
47	chr19:18942200-18942600	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
48	chr19:18942200-18942600	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
49	chr19:18942200-18942600	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
50	chr19:18942200-18942600	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links